Cold & Cough Remedies - Sweden

  • Sweden
  • In Sweden, the revenue in the Cold & Cough Remedies market market reached US$129.80m in 2024.
  • It is projected that the market will grow at an annual rate of 4.53% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, with US$11,190.00m in 2024.
  • On a per person basis, in 2024, the revenue generated amounts to US$12.16.
  • Despite the high prevalence of cold and cough remedies in the Swedish OTC Pharmaceuticals market, there is a growing shift towards natural and herbal remedies.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Sweden has been experiencing steady growth in recent years.

Customer preferences:
Swedish consumers have shown a growing preference for natural and herbal remedies for cold and cough symptoms. This shift in preference can be attributed to the increasing awareness about the potential side effects of conventional over-the-counter medications. Consumers are now seeking out products that are made from natural ingredients and are perceived to be safer and gentler on the body. This trend is in line with the global movement towards more natural and holistic approaches to healthcare.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Sweden is the rising demand for immune-boosting products. With the increasing focus on preventive healthcare, consumers are looking for products that can help strengthen their immune system and reduce the risk of catching a cold or cough. This has led to a surge in the popularity of products that contain ingredients like vitamin C, zinc, and echinacea, which are known for their immune-boosting properties.Another trend in the market is the growing popularity of combination products that offer multiple benefits. Consumers are looking for remedies that not only provide relief from cold and cough symptoms but also address other related issues such as congestion, sore throat, and sinus pressure. Combination products that offer a holistic solution to these symptoms have gained significant traction in the market.

Local special circumstances:
Sweden has a high level of healthcare awareness and a strong healthcare system, which has contributed to the growth of the Cold & Cough Remedies market. The country has a well-established tradition of self-care, with consumers taking an active role in managing their health. This has created a favorable environment for the growth of the over-the-counter market, including the Cold & Cough Remedies segment.

Underlying macroeconomic factors:
The growing prevalence of cold and cough symptoms in Sweden can be attributed to several underlying macroeconomic factors. The country experiences long and cold winters, which increases the risk of respiratory infections. Additionally, the high level of air pollution in some urban areas can also contribute to the frequency and severity of cold and cough symptoms. These factors drive the demand for Cold & Cough Remedies in the market.In conclusion, the Cold & Cough Remedies market in Sweden is witnessing growth due to shifting customer preferences towards natural and herbal remedies, the rising demand for immune-boosting products, and the popularity of combination products. The local special circumstances, including the high level of healthcare awareness and the tradition of self-care, have also contributed to the market's development. The underlying macroeconomic factors, such as the climate and air pollution, further drive the demand for Cold & Cough Remedies in Sweden.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)